BioTime Inc. | |
Stock Exchange | NYSE |
EPS |
$0.44 |
Market Cap |
$141.17 M |
Shares Outstanding |
149.64 M |
Public Float |
125.51 M |
BioTime Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
126.88 M |
Public Float |
88.71 M |
Address |
1010 Atlantic Avenue Alameda California 94501 United States |
Employees | - |
Website | http://www.biotimeinc.com |
Updated | 07/08/2019 |
BioTime, Inc. is a clinical-stage biotechnology company, which deals with degenerative diseases. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. |